糖化白蛋白标准化挑战:方法异质性与定量差异
本研究比较了靶向自下而上蛋白质组学方法(ID-LC-MS/MS)、酶法及日本临床化学会(JSCC)参考方法,分析129份供者血清和认证参考物质(JCCRM-611),发现靶向Lys-525位点的定量在高GA水平下负偏倚增大,而针对所有糖化赖氨酸残基的定量更接近生物学相关GA值,建议将总糖化赖氨酸残基作为优选的被测量定义以推进标准化。
要点
- 靶向Lys-525位点的GA定量在高GA水平下呈现进行性增大的负系统偏倚。
- 总糖化赖氨酸残基定量(如JSCC法)比Lys-525位点特异测量更接近生物学相关GA值。
- GA标准化需采用总糖化赖氨酸残基作为优选被测量定义以提高检测准确性和临床可比性。
核心结论
- GA测量标准化需精确且普遍接受的被测量定义以解决分析差异。
- 靶向所有糖化赖氨酸残基的定量比Lys-525位点特异测量更接近生物学相关GA值。
- 建议将白蛋白总糖化赖氨酸残基作为优选的被测量定义以改进检测准确性和临床可比性。
研究设计与样本
- 比较靶向自下而上蛋白质组学方法(ID-LC-MS/MS)、酶法和日本临床化学会(JSCC)参考方法。
- 分析129份供者血清标本和认证参考物质(JCCRM-611)以评估方法可比性。
- 检查白蛋白Lys-525位点的GA浓度依赖性糖化动力学。
主要发现
- 优化的靶向自下而上蛋白质组学方法与酶法及JSCC参考方法均呈强相关(r=0.986)。
- 在高GA水平下观察到进行性增大的负系统偏倚,证实Lys-525在高水平时低估GA。
- 随着总GA浓度增加,Lys-525位点的糖化比率相较于总糖化赖氨酸残基持续下降。
关键数值与推荐
- 靶向自下而上蛋白质组学方法与酶法及JSCC参考方法的相关性r=0.986。
- 在高GA水平下Lys-525位点呈现进行性增大的负系统偏倚。
- Lys-525位点糖化比率随总GA浓度增加而相较于总糖化赖氨酸残基持续下降。
临床怎么用
- 临床解读GA结果时需注意方法异质性导致的定量差异。
- 优先选择基于总糖化赖氨酸残基定义的GA检测方法以提高可比性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glycated albumin (GA) is a valuable biomarker for monitoring glycemic status. However, measurement standardization is challenged by methodological heterogeneity, where different analytical principles and target measurands cause quantification discrepancies. This study systematically compared prevailing methodologies to identify a robust reference measurement procedure for widespread standardization. METHODS: We compared a targeted bottom-up proteomics method (ID-LC-MS/MS) with an enzymatic assay and the Japan Society of Clinical Chemistry (JSCC) reference method. A cohort of 129 donor serum specimens and certified reference materials (JCCRM-611) were analyzed to assess methodological comparability. Furthermore, GA concentration-dependent glycation kinetics at the Lys-525 site of albumin was examined. RESULTS: The optimized targeted bottom-up proteomics method showed a strong correlation (r = 0.986) with both the enzymatic assay and JSCC reference method. However, a progressively increasing negative systematic bias was observed at higher GA levels, confirming that Lys-525 underestimates GA at higher levels. In addition, with increasing overall GA concentration, the glycation ratio at the Lys-525 site consistently declined compared to the total glycated lysine residues. CONCLUSIONS: The standardization of GA measurements requires a precise, universally accepted definition to address analytical discrepancies. The present results indicate that quantification targeting all glycated lysine residues (as in the JSCC method) aligns more closely with biologically relevant GA values than site-specific measurement at Lys-525, which shows greater bias at higher concentrations. Therefore, further GA standardization would focus on adopting total glycated lysine residues on albumin as the preferred measurand definition, to improve detection accuracy and clinical comparability.
引用
- Zheng H, Wu R, Zhang L, et al. Standardization Challenges in Glycated Albumin Measurement: Methodological Heterogeneity and Quantification Discrepancies. Clin Chem. 2026. PMID: 42240842. doi:10.1093/clinchem/hvag055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。